Titan International Reports Mixed Q4 & FY2025 Results, Issues 2026 Guidance with Significant Non-Cash Tax Allowance
summarizeZusammenfassung
Titan International reported mixed financial results for Q4 and full-year 2025. While Q4 2025 saw revenue growth of 7% and an 18% increase in Adjusted EBITDA, the company recorded a significant GAAP net loss of $(56.0) million, primarily due to a $40.0 million non-cash deferred tax valuation allowance. For the full year 2025, net sales slightly decreased, and Adjusted EBITDA declined. Critically, free cash flow turned negative, moving from $75.9 million positive in 2024 to $(24.6) million negative in 2025. The company provided 2026 guidance anticipating modest revenue and Adjusted EBITDA growth, suggesting a recovery from the weaker full-year 2025 performance. Investors should note the impact of the non-cash tax allowance on reported earnings and monitor the company's ability to improve free cash flow and achieve its 2026 outlook.
check_boxSchlusselereignisse
-
Q4 2025 Financial Performance
Revenues grew 7% to $410.4 million, and Adjusted EBITDA increased 18% to $11 million. However, the company reported a GAAP net loss of $(56.0) million, compared to a net income of $1.3 million in Q4 2024.
-
Full Year 2025 Overview
Net sales for the full year 2025 were $1,828.4 million, a slight decrease from $1,845.9 million in 2024. Adjusted EBITDA for the year was $101.5 million, down from $128.1 million in 2024.
-
Significant Non-Cash Tax Allowance
The Q4 2025 net loss was primarily driven by a $40.0 million non-cash deferred tax valuation allowance established during the quarter.
-
2026 Financial Outlook
The company expects Q1 2026 sales between $490 million and $510 million, with Adjusted EBITDA between $28 million and $33 million. For the full year 2026, revenue is projected in the $1.85 billion to $1.95 billion range, and Adjusted EBITDA between $105 million and $115 million.
auto_awesomeAnalyse
Titan International reported mixed financial results for Q4 and full-year 2025. While Q4 2025 saw revenue growth of 7% and an 18% increase in Adjusted EBITDA, the company recorded a significant GAAP net loss of $(56.0) million, primarily due to a $40.0 million non-cash deferred tax valuation allowance. For the full year 2025, net sales slightly decreased, and Adjusted EBITDA declined. Critically, free cash flow turned negative, moving from $75.9 million positive in 2024 to $(24.6) million negative in 2025. The company provided 2026 guidance anticipating modest revenue and Adjusted EBITDA growth, suggesting a recovery from the weaker full-year 2025 performance. Investors should note the impact of the non-cash tax allowance on reported earnings and monitor the company's ability to improve free cash flow and achieve its 2026 outlook.
Zum Zeitpunkt dieser Einreichung wurde TWI bei 10,51 $ gehandelt an der NYSE im Sektor Manufacturing, bei einer Marktkapitalisierung von rund 672,1 Mio. $. Die 52-Wochen-Handelsspanne lag zwischen 5,93 $ und 11,70 $. Diese Einreichung wurde mit negativer Marktstimmung und einem Wichtigkeitsscore von 7 von 10 bewertet.